...
首页> 外文期刊>Cancer Management and Research >A Novel Preoperative Nomogram for Predicting Lymph Node Invasion in Renal Cell Carcinoma Patients Without Metastasis
【24h】

A Novel Preoperative Nomogram for Predicting Lymph Node Invasion in Renal Cell Carcinoma Patients Without Metastasis

机译:用于预测肾细胞癌患者淋巴结侵袭的新型术前罗布图,没有转移

获取原文

摘要

Objective: To provide a preoperative predictive model to support clinical decision-making regarding the selection of in renal cell carcinoma (RCC) patients who will benefit the most from lymph node dissection. Methods: This retrospective analysis enrolled 374 RCC patients without distant metastasis who underwent surgical treatment from January 2006 to December 2017. The relationships between lymph node invasion (LNI) and age at surgery; gender; body mass index(BMI); the presence of clinical symptoms such as flank pain, hematuria or a palpable mass; clinical T stage (cT stage); clinical N stage (cN stage); and the results of routine hematological and serum biochemical analyses were investigated. All the variables were included in univariate and multivariate logistic regression analyses, and the significant variables were then included in a novel nomogram to predict the probability of LNI. Then, we calibrated the nomogram with an internal validation set. Results: Six of eighteen?variables were significant in the univariate logistic regression analysis. After multivariate logistic regression analysis, age at surgery (OR=0.643, 95% CI: 0.421–0.975), cT stage (OR=3.034, 95% CI: 1.541–5.926), cN stage (OR=6.353, 95% CI: 3.273–12.456), lymphocyte percentage (OR=0.481, 95% CI: 0.256–0.894), and the presence of clinical symptoms (OR=2.045, 95% CI: 1.065–3.924) were independent predictors of LNI and were included in the nomogram. The C-index of this nomogram was 0.824. Conclusion: Preoperative basic laboratory findings combined with the results of a physical examination and radiological examination can indicate the probability of LNI in RCC patients.
机译:目的:提供一种术前预测模型,以支持有关选择肾细胞癌(RCC)患者的临床决策,这些患者将受益于淋巴结解剖最大的患者。方法:该回顾性分析注册了374例RCC患者,没有远处转移的患者,他们从2006年1月到2017年12月接受手术治疗。淋巴结入侵(LNI)与手术年龄的关系;性别;体重指数(BMI);存在临床症状,如侧面疼痛,血尿或可触及的质量;临床T阶段(CT阶段);临床n阶段(CN阶段);研究了常规血液学和血清生物化学分析的结果。所有变量都包括在单变量和多变量逻辑回归分析中,然后将重要变量包括在新颖的甲型图中以预测LNI的概率。然后,我们使用内部验证集校准了墨顶图。结果:十八六个?变量在单变量逻辑回归分析中是显着的。在多变量后退回归分析后,手术年龄(或= 0.643,95%CI:0.421-0.975),CT阶段(或= 3.034,95%CI:1.541-5.926),CN阶段(或= 6.353,95%CI: 3.273-12.456),淋巴细胞百分比(或= 0.481,95%CI:0.256-0.894),以及临床症状的存在(或= 2.045,95%CI:1.065-3.924)是LNI的独立预测因子,并包括在内罗维图。该墨顶图的C指数为0.824。结论:术前基本实验室调查结果结合物理检查和放射学检查的结果,可以表明RCC患者的LNI概率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号